Importancia de las complicaciones derivadas del tratamiento antitrombótico | Titulo Master en Trombosis

Increased risk of thrombosis in antiphospholipid síndrome patients treated with direct oral anticoagulants. Results from international patient-level data metaanálisis Autoinmunity Reviews

[vc_tta_section i_icon_fontawesome="fa fa-folder-open-o" title="Abstract"... Leer más →

Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents

Target-specific oral anticoagulants (TSOACs) dabigatran, rivaroxaban and apixaban are approved for the prevention and treatment of... Leer más →

European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation

New oral anticoagulants (NOACs)... Leer más →

Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation

Objetive To examine... Leer más →

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

Background Four new oral anticoagulants compare favourably with warfarin for... Leer más →

Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: A meta-analysis of interventional trials

Background New oral anticoagulants represent an alternative to standard... Leer más →